Rempex Pharmaceuticals, Inc.
- UEI
- K72PFPZ54YV8
- CAGE
- 6LCR5
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Advanced development of RPX7009 | Office of the Assistant Secretary for Preparedness and Response | $55,849,364 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Molecular archaeology: vintage beta lactams for resistant gram negative infectio | National Institutes of Health | $407,413 |
Quick answers
Is Rempex Pharmaceuticals, Inc. registered in SAM.gov?
Rempex Pharmaceuticals, Inc.'s SAM.gov registration expired on June 10, 2020.
What is Rempex Pharmaceuticals, Inc.'s most recent federal award?
Rempex Pharmaceuticals, Inc.'s most recent federal contract award is Advanced development of RPX7009 (HHSO100201400002C), from Office of the Assistant Secretary for Preparedness and Response, on February 5, 2014.
On GovTribe
See Rempex Pharmaceuticals, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors